Thinking about CNS metastasis in cutaneous lymphoma: Analysis of existing data

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mortality in these patients. Our analyses indicated that neurologic surveillance after the diagnosis of MF is crucial. Review of systems should include change in mentation, vestibular, and ocular symptoms. Progression to CNS involvement does not always occur in tandem with cutaneous disease burden. Single-agent therapies can delay disease progression and improve prognosis. Multi-agent treatment does not improve survival.

Original languageEnglish (US)
Pages (from-to)14-18
Number of pages5
JournalLeukemia Research Reports
Volume8
DOIs
StatePublished - 2017

Fingerprint

Lymphoma
Neoplasm Metastasis
Skin
Skin Diseases
Nervous System
Disease Progression
Survival
Mortality
Therapeutics

Keywords

  • Brain metastasis
  • Central nervous system diseases
  • Cutaneous T-cell lymphoma
  • Lymphoma
  • Mycosis fungoides

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Thinking about CNS metastasis in cutaneous lymphoma : Analysis of existing data. / Yang, Yi; Wickless, Heather.

In: Leukemia Research Reports, Vol. 8, 2017, p. 14-18.

Research output: Contribution to journalReview article

@article{630ab7d6adff4cf0934e0eff6d746820,
title = "Thinking about CNS metastasis in cutaneous lymphoma: Analysis of existing data",
abstract = "To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mortality in these patients. Our analyses indicated that neurologic surveillance after the diagnosis of MF is crucial. Review of systems should include change in mentation, vestibular, and ocular symptoms. Progression to CNS involvement does not always occur in tandem with cutaneous disease burden. Single-agent therapies can delay disease progression and improve prognosis. Multi-agent treatment does not improve survival.",
keywords = "Brain metastasis, Central nervous system diseases, Cutaneous T-cell lymphoma, Lymphoma, Mycosis fungoides",
author = "Yi Yang and Heather Wickless",
year = "2017",
doi = "10.1016/j.lrr.2017.10.001",
language = "English (US)",
volume = "8",
pages = "14--18",
journal = "Leukemia Research Reports",
issn = "2213-0489",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Thinking about CNS metastasis in cutaneous lymphoma

T2 - Analysis of existing data

AU - Yang, Yi

AU - Wickless, Heather

PY - 2017

Y1 - 2017

N2 - To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mortality in these patients. Our analyses indicated that neurologic surveillance after the diagnosis of MF is crucial. Review of systems should include change in mentation, vestibular, and ocular symptoms. Progression to CNS involvement does not always occur in tandem with cutaneous disease burden. Single-agent therapies can delay disease progression and improve prognosis. Multi-agent treatment does not improve survival.

AB - To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mortality in these patients. Our analyses indicated that neurologic surveillance after the diagnosis of MF is crucial. Review of systems should include change in mentation, vestibular, and ocular symptoms. Progression to CNS involvement does not always occur in tandem with cutaneous disease burden. Single-agent therapies can delay disease progression and improve prognosis. Multi-agent treatment does not improve survival.

KW - Brain metastasis

KW - Central nervous system diseases

KW - Cutaneous T-cell lymphoma

KW - Lymphoma

KW - Mycosis fungoides

UR - http://www.scopus.com/inward/record.url?scp=85032009050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032009050&partnerID=8YFLogxK

U2 - 10.1016/j.lrr.2017.10.001

DO - 10.1016/j.lrr.2017.10.001

M3 - Review article

C2 - 29085772

AN - SCOPUS:85032009050

VL - 8

SP - 14

EP - 18

JO - Leukemia Research Reports

JF - Leukemia Research Reports

SN - 2213-0489

ER -